INDOCO - Indoco Remedies

Indoco Remedies

INDOCO · Pharma > Pharmaceuticals & Drugs · Chairman: Suresh G Kare · MD: Aditi Panandikar · Listing date: Jan. 15, 2005 · Employees: 6000 · Mumbai · http://www.indoco.com

Stock Price vs Company Growth

3.8%

3.1%

5.3%

3.9%

10.4%

17.3%

12.7%

10y

2.5%

all

9.7%

🤔 How to analyze this graph?

Last Traded Price

₹ 236 3.8%

214

287

Company Overview

Sales

1,873 Cr

Growth: 8.9%

Profit after Tax

-95.5 Cr

Growth: -3.5%

Small Cap

2,179 Cr

P/E: 694.4x

Industry P/E: 32.5x

Fundamentals

Sales (Cr)	₹ 1,873
Growth	8.9%
EBITDA	8.8%
P/S	1.2x
Dividend	0.1%
P/E	694.4x
Book Value	₹ 98.3
PEG Ratio	81.5x
ROE	-10.1%
P/B	2.5x

Shareholding Pattern

Institutions

Nippon Life India Trustee Ltd A/C Nippon Small Cap Fund

6.2 %

Icici Prudential Pharma Healthcare And Diaganostics (Phd Fund

4.82 %

Sundaram Mutual Fund A/C Sundaram Small Cap

1.3 %

Mangeshi Investment Private Limited

1.26 %

Adity Birla Life Trustee Pvt. Ltd

1.23 %

Promoters

Spa Holdings Pvt Ltd

19.85 %

Shanteri Investment Pvt Ltd

17.07 %

Panandikar Aditi Milind

6.02 %

Ramani Madhura Anup

5.61 %

Kare Aruna Suresh

5.19 %

Others

Increase Decrease No change

Company Profile Detailed

Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company caters to both domestic and International markets.

Belongs to (9 Indices) view more

Investors (149)

sbi.magn...

first.st...

rajendra...

Followers (6)

nitin2

keerthi

deepak